Clinical trial
A Randomized Study of Neoadjuvant Chemoradiotherapy With or Without Intensification With the FOLFOXIRI Chemo-regimen for High-risk Locally Advanced Rectal Cancer
NCT03997435 is registered in ClinicalTrials.gov with CCTU as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Study of Neoadjuvant Chemoradiotherapy With or Without Intensification With the FOLFOXIRI Chemo-regimen for High-risk Locally Advanced Rectal Cancer
- Lead sponsor
- CCTU
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- September 10, 2019
- Completion date
- December 31, 2027
- Enrollment
- 72 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer